TU-100 (Daikenchuto) and Ginger Ameliorate Anti-CD3 Antibody Induced T Cell-Mediated Murine Enteritis: Microbe-Independent Effects Involving Akt and NF-κB Suppression
Creators
- 1. University of Chicago
- 2. Tsumura and Co.
- 3. Asahikawa Medical University
- 4. Sapporo Higashi Tokushukai Hospital
Description
The Japanese traditional medicine daikenchuto (TU-100) has anti-inflammatory activities, but the mechanisms remain incompletely understood. TU-100 includes ginger, ginseng, and Japanese pepper, each component possessing bioactive properties. The effects of TU-100 and individual components were investigated in a model of intestinal T lymphocyte activation using anti-CD3 antibody. To determine contribution of intestinal bacteria, specific pathogen free (SPF) and germ free (GF) mice were used. TU-100 or its components were delivered by diet or by gavage. Anti-CD3 antibody increased jejunal accumulation of fluid, increased TNFα, and induced intestinal epithelial apoptosis in both SPF and GF mice, which was blocked by either TU-100 or ginger, but not by ginseng or Japanese pepper. TU-100 and ginger also blocked anti-CD3-stimulated Akt and NF-κB activation. A co-culture system of colonic Caco2BBE and Jurkat-1 cells was used to examine T-lymphocyte/epithelial cells interactions. Jurkat-1 cells were stimulated with anti-CD3 to produce TNFα that activates epithelial cell NF-κB. TU-100 and ginger blocked anti-CD3 antibody activation of Akt in Jurkat cells, decreasing their TNFα production. Additionally, TU-100 and ginger alone blocked direct TNFα stimulation of Caco2BBE cells and decreased activation of caspase-3 and polyADP ribose. The present studies demonstrate a new anti-inflammatory action of TU-100 that is microbe-independent and due to its ginger component.
Data availability
The authors confirm that all data underlying the findings are fully available without restriction. All data are included within the manuscript and Supporting Information files.Files
journal.pone.0097456.pdf
Files
(1.6 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:d0b0bf38a4cbf4b22e65421e2cc10f9c |
1.5 MB | Preview Download |
|
md5:3bd69f695d70421f64850115cf80b19d
|
72.3 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0097456
- Other
- oai:uchicago.tind.io:10391
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases
- P30 DK42086
- National Institute of Diabetes and Digestive and Kidney Diseases
- DK47722
- National Institute of Diabetes and Digestive and Kidney Diseases
- DK097268
- National Institute of Diabetes and Digestive and Kidney Diseases
- NCCAM AT004418
- National Institute of Diabetes and Digestive and Kidney Diseases
- AT005362
- National Institutes of Health
- CA036745
- Samuel Freedman Research Laboratories for Gastrointestinal Cancer Research
- University of Chicago Comprehensive Cancer Center